Carien L Creutzberg
Overview
Explore the profile of Carien L Creutzberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
142
Citations
5102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suvaal I, van den Hout W, Hummel S, Mens J, Tuijnman-Raasveld C, Velema L, et al.
Radiother Oncol
. 2024 Dec;
203():110683.
PMID: 39675572
Purpose: To compare the cost-effectiveness of a nurse-led sexual rehabilitation intervention with standard care in women treated with external beam radiotherapy, with or without brachytherapy, for gynaecological cancers. Methods: Eligible...
2.
Serbes E, Horeweg N, Parra-Herran C, van Rijnsoever R, Jobsen J, Jurgenliemk-Schulz I, et al.
Mod Pathol
. 2024 Nov;
38(3):100660.
PMID: 39577664
Of the 4 molecular subtypes of endometrial cancer (EC), p53-abnormal (p53abn) EC is associated with abundant copy number alterations and the worst clinical outcome. Patients with p53abn EC have the...
3.
Oberguggenberger A, Engele V, Schmalz C, Nordin A, Bjelic-Radisic V, Lanceley A, et al.
BMC Cancer
. 2024 Nov;
24(1):1374.
PMID: 39523323
Background: The European Organization of Research and Treatment of Cancer (EORTC) has recently developed and validated a patient-reported outcome measure (PROM) for sexual health (SH) in cancer patients. Here, we...
4.
Matias-Guiu X, Lax S, Raspollini M, Palacios J, Zheng W, Liu C, et al.
Eur J Cancer
. 2024 Nov;
213:115115.
PMID: 39520836
Incorporation of pathological and (not mandatory) molecular features into the new FIGO 2023 staging system has generated some controversy. Several validations have been published recently that demonstrated the higher prognostic...
5.
Corbeau A, van Gastel P, Wielopolski P, de Jong N, Creutzberg C, van der Heide U, et al.
Phys Imaging Radiat Oncol
. 2024 Nov;
32:100651.
PMID: 39498310
Bone marrow (BM) damage due to chemoradiotherapy can increase BM fat in cervical cancer patients. Water-fat magnetic resonance (MR) scans were performed on a phantom and a healthy female volunteer...
6.
Creutzberg C, Kim J, Eminowicz G, Allanson E, Eberst L, Kim S, et al.
Lancet Oncol
. 2024 Aug;
25(9):e420-e431.
PMID: 39214113
The Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Consensus Conference on Clinical Research (ECCC) was held in Incheon, South Korea, Nov 2-3, 2023. The aims were to develop consensus statements for...
7.
Schmalz C, Oberguggenberger A, Nagele E, Bliem B, Lanceley A, Nordin A, et al.
BMC Palliat Care
. 2024 Jul;
23(1):189.
PMID: 39075384
Objectives: Sexuality is an important dimension of health-related quality of life (HRQOL) in cancer patients. Studies evidence that most patients report impairments of their sexual health related to their disease...
8.
Ezendam N, de Rooij B, Creutzberg C, Kruitwagen R, van Lonkhuijzen L, Apperloo M, et al.
Gynecol Oncol
. 2024 Jul;
188:169-183.
PMID: 38970844
Background: Evidence on the optimal follow-up schedule after endometrial cancer is lacking. The study aim was to compare satisfaction with care between women who received reduced follow-up care and women...
9.
Suvaal I, Hummel S, Mens J, Tuijnman-Raasveld C, Tsonaka R, Velema L, et al.
Br J Cancer
. 2024 Jul;
131(5):808-819.
PMID: 38961193
Background: The multicentre randomised SPARC trial evaluated the efficacy of a nurse-led sexual rehabilitation intervention on sexual functioning, distress, dilator use, and vaginal symptoms after radiotherapy for gynaecological cancers. Methods:...
10.
Author Correction: Prediction of recurrence risk in endometrial cancer with multimodal deep learning
Volinsky-Fremond S, Horeweg N, Andani S, Barkey Wolf J, Lafarge M, de Kroon C, et al.
Nat Med
. 2024 Jul;
30(7):2092.
PMID: 38951637
No abstract available.